EUVIMEDEUVIMED entdecken
Crossref

HBV enfeksiyonunun tedavisinde CRISPR / Cas9 gen düzenleme sisteminin kullanımı

Medine Karadağ-Alpaslan-

Gene Editing · 2020

DOI: 10.29228/genediting.40389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gene Editing, 2020. Verfasst von Medine Karadağ-Alpaslan-. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

: Hepatitis B disease is an infectious disease caused by the Hepatitis B virus (HBV) which may have different consequences such as cirrhosis and liver cancer. Although there is an effective vaccine against HBV, it is still a serious health problem for underdeveloped and some developing countries where the vaccination rate is low. Current treatments cannot clear all the viral infections. Therefore, there is an urgent need for definitive HBV treatment. The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) method is frequently used in vitro and in vivo for genetic modifications, including targeting the HBV genome. Therefore, in this review, the use of CRISPR/Cas9 technology in the HBV genome for treatment purposes will be discussed with the aid of recent literature.

Zitieren

APA

Karadağ-Alpaslan-, M. (2020). HBV enfeksiyonunun tedavisinde CRISPR / Cas9 gen düzenleme sisteminin kullanımı. Gene Editing. https://doi.org/10.29228/genediting.40389

Vancouver

Karadağ-Alpaslan- M. HBV enfeksiyonunun tedavisinde CRISPR / Cas9 gen düzenleme sisteminin kullanımı. Gene Editing. 2020. doi:10.29228/genediting.40389

BibTeX
@article{KaradaAlpaslan2020,
  author = {Karadağ-Alpaslan-, Medine},
  title = {HBV enfeksiyonunun tedavisinde CRISPR / Cas9 gen düzenleme sisteminin kullanımı},
  journal = {Gene Editing},
  year = {2020},
  doi = {10.29228/genediting.40389}
}
Kostenlos starten →